EX-32 5 d559900dex32.htm EX-32 EX-32

Exhibit 32

Meridian Bioscience, Inc.

Certification of Chief Executive Officer and Chief Financial Officer

Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the filing with the Securities and Exchange Commission of the Quarterly Report of Meridian Bioscience, Inc. (the “Company”) on Form 10-Q for the period ended March 31, 2018 (the “Report”), the undersigned officers of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of their knowledge:


  1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


  2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


/s/ Jack Kenny

Jack Kenny

Chief Executive Officer
May 10, 2018

/s/ Melissa A. Lueke

Melissa A. Lueke

Executive Vice President and
Chief Financial Officer
May 10, 2018